8/10/21 8/10/21

Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth

Entourage Health Corp. announced today its financial results for the three and six months ended June 30, 2021.

7/20/21 7/20/21

Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET

Entourage Health Corp. is pleased to announce preliminary unaudited revenues of $13.6 million for the three months ended June 30, 2021, representing another sequential quarter of record sales growth across its adult-use and medical sales channels.

7/16/21 7/16/21

Entourage Health Announces Debut of New Ticker “ENTG” on TSX Venture

Following corporate rebrand from WeedMD Inc., the Company’s common shares under “WMD” will trade on the TSXV under new ticker “ENTG” commencing today

7/14/21 7/14/21

WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.

On closing, merged company to combine innovative medical business, low-cost cultivation, specialized craft cannabis, micropropagation, and solventless...

7/5/21 7/5/21

WeedMD Inc. Announces Intent to Change Corporate Name to Entourage Health Corp.

Company reports results of Annual General & Special Meeting of Shareholders held on June 30, 2021 which includes overwhelming shareholder approval...

6/29/21 6/29/21

WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth

WeedMD announced today its financial results for the three months ended March 31, 2021.

6/28/21 6/28/21

WeedMD Expands its Color Cannabis Brand into the Province of New Brunswick

Award-winning adult-use brand Color now available coast-to-coast in 90% of Canada’s retail markets

6/15/21 6/15/21

WeedMD Sells Fully Licensed Bowmanville Operating Assets

Closes share-sale transaction with Final Bell Canada Inc. following Starseed Medicinal’s full production and product fulfillment move to Company’s consolidated London-area facilities...

5/31/21 5/31/21

WeedMD and Privately Owned CannTx Life Sciences Sign Letter of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio

WeedMD is pleased to announce it has signed a Letter of Intent to acquire all of the issued and outstanding shares of renowned craft cultivator CannTx Life Sciences Inc...

5/31/21 5/31/21

WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million

WeedMD announced today its financial results for the fiscal year ended December 31, 2020.

5/21/21 5/21/21

WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st

Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved

5/17/21 5/17/21

WeedMD Launches New Product Collaboration with CannTx Life Sciences for Release of Limited Edition Cultivars to Starseed Medicinal

Company expands into premium craft offering with exclusive licensing for ‘Limited Edition’ high-THC craft strains Rockstar Tuna and Royal Goddess for Starseed patients...

5/14/21 5/14/21

WeedMD Inc. Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements

WeedMD is providing a bi-weekly update on the status of the management cease trade order granted on May 3, 2021 (the "MCTO") by its principal regulator...

5/4/21 5/4/21

WeedMD Management to Present at Canaccord Genuity’s Annual Global Cannabis Virtual Conference on May 11th

WeedMD is pleased to announce that George Scorsis, WeedMD’s CEO and Executive Chairman, and the Company’s newly appointed CFO Beth Carreon are scheduled...

5/3/21 5/3/21

WeedMD Inc. Granted Management Cease Trade Order

WeedMD confirmed today that further to its news release dated April 21, 2021, the Company's principal regulator, the Ontario Securities Commission...

4/21/21 4/21/21

WeedMD Announces Delayed Filing of its 2020 Annual Financial Disclosure

WeedMD announced today that the filing of its audited annual financial statements, management's discussion and analysis, and related CEO...

4/19/21 4/19/21

WeedMD Announces Participation in Upcoming Investor Events

WeedMD is pleased to announce that George Scorsis, WeedMD’s CEO and Executive Chair, is scheduled to participate in the following upcoming investor events...